Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00879723 · ClinicalTrials.gov registry record · Phase 1

Burn Micronutrient Repletion Pilot Study

A Phase 1 study, sponsored by Southern Illinois University.

Completed
Registry status
Phase 1
Development phase
28
Enrollment target

NCT00879723: Completed Phase 1 study, sponsored by Southern Illinois University.

NCT00879723 is a Phase 1 study that has completed, run by Southern Illinois University. The registered enrollment target is 28 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (53% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00879723, a Phase 1 study, has completed, sponsored by Southern Illinois University.

COMPLETED
Registry status
Phase 1
Development phase
28 participants
Enrollment target

Study Summary

Burn injury patients undergo a series of metabolic changes that, if untreated, could lead to reduced health outcomes. Nutrition is thought to play a vital role in post-burn recovery. The research team developed a novel vitamin and mineral supplementation protocol based on current scientific literature. The study will test the hypothesis that the novel vitamin and mineral supplement regimen will improve adult patient recovery from burn injury.

Interventions

  • DIETARY_SUPPLEMENT Vitamin and Mineral supplementation

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2010-08
Est. Completion 2011-08
Phase Phase 1
Southern Illinois University

21 total trials

What the finished NCT00879723 record still lists

NCT00879723 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (53% lower).

The record links to 0 conditions, and to 1 intervention - of which Vitamin and Mineral supplementation is the first listed.

NCT00879723 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00879723 about?

NCT00879723 is a clinical study titled "Burn Micronutrient Repletion Pilot Study". Burn injury patients undergo a series of metabolic changes that, if untreated, could lead to reduced health outcomes. Nutrition is thought to play a vital role in post-burn recovery. The research team developed a novel vitamin and mineral supplementation protocol based on current scientific literatu...

What is the current status of trial NCT00879723?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2010-08. Estimated completion is 2011-08.

What interventions are being tested in trial NCT00879723?

The interventions under investigation include: Vitamin and Mineral supplementation (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT00879723?

This trial is sponsored by Southern Illinois University, which has 21 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00879723's enrollment target sits among peer trials

28 1447th of 2000 higher than 538 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03471117 · 28 participants · Phase 4

    Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

  • NCT03523975 · 28 participants · Phase 1

    Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

  • NCT03608631 · 28 participants · Phase 1

    iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

  • NCT03810651 · 28 participants · Early Phase 1

    Pencil Beam Scanning in Patients With Renal Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00879723, the US trial registry maintained by the National Library of Medicine. NCT00879723 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.